Uppercase Branding | Healthcare

Creating Extraordinary Brands for Healthcare Businesses



Uppercase Branding prides itself on its ability to bring fresh thinking and applied learning from across business segments to any challenge in any space. This approach has fueled our growth in a range of industries but particularly in the healthcare field. Our subject matter expertise in this discipline combined with our continued innovation in other domains lets us efficiently, creatively, quickly and cost effectively perform for our healthcare, wellness and life science client base. 

Our Model:

We help you create new brands or rejuvenate legacy ones using insightful research that informs and inspires our persuasive narratives and striking designs. This compelling creative work is developed by a network of subject matter experts and creative specialists, and delivered by the firm’s founding partners. Our virtual hub & spoke model produces content in days not months for thousands of dollars not tens of thousands.

Our Mission:

Help our clients create new healthcare brands or rejuvenate tired ones at minimal fees.

Our Method:

There is no madness to our method. We don’t use jargon. We don’t employ any dogs or ponies. Smoke is for fires and mirrors are for reflection. What we do is our level best to understand your challenge, craft a coherent plan and bring that plan to life with compelling ideas that resonate with the target.

Our Services:

Uppercase delivers three buckets of services, each one building upon the other. While we know that they work best together, each offering is designed to stand alone and meet any individual client need.


1.   Brand Strategy - Inform and Inspire

At Uppercase, brand strategy is all about asking the best questions to uncover the essential insights that inform and inspire the most compelling message. Our imaginative combination of research and discovery uses innovative techniques that peel the onion to reveal your brand’s sustained competitive advantage.


  • Qualitative research

  • Quantitative research

  • Internal ideation sessions

  • Messaging platforms

    • Internal yet inspirational positioning documents that drive the development of the creative work. Who you are, what you stand for, what problem do you solve, how you are different, who you are speaking to and why prospects should buy. These can include:

      • Short form positioning statement

      • Long form messaging, e.g. key selling points, about, etc.

      • Target audience personas

2.   Creative Content - Nodding Yes

Relevancy to the audience is priority one. Uppercase creates content that generates awareness, interest and action among the target.  When your audience is exposed to the right message, they are nodding yes and thinking “that’s me.”



  • Naming - No single marcom tool is used more frequently and more widely than the name. It is the single most powerful advertisement for your brand.

  • Architecture and Name Rationalization - We know that over time products and services proliferate and pretty soon you have a sub-optimized brand architecture and maybe an inefficient naming process.

  • Visual Design - Your brand graphically delivered, your message visually enhanced.

  • Messaging - Slogans, copywriting, texts, emails, tweets, blogs, posts, advertising, news releases, websites, collateral, identity systems, speeches, and presentations all strategically reinforcing and creatively engaging.

  • Guidelines - Brand identity guides that aid communication professionals in delivering the message.


3.   Roadmap - The Action Plan for Launch

Clear, concise and specific actions that put your brand in front of the audiences that matter.


  • A scheduling and sequencing timetable to effect maximum impact at minimal budgets.

  • Complete list of media outlets and contact information that exposes your brand to opinion leaders and buyers.

  • Well-crafted feedback loops to optimize follow up.


Healthcare | Clients

Uppercase Branding has domain expertise in every healthcare sector including:

  • Medical Device, Dx, Equipment and Supplies

  • Pharmaceuticals (proprietary, generic, bio, OTC)

  • Wearables, Digital Health

  • Services and Facilities

  • Biotech

  • Medical Services, Insurance, and Managed Care

  • OTC and HBA, B2B and B2C

Our Clients are huge, small and every size in between. They include:

  • Cardinal Health

  • Clinical Genomics

  • Clorox

  • Cordis

  • Edwards Lifesciences

  • Gambro

  • Haisco

  • HealthBox

  • iDev

  • iRhythm

  • J&J

  • Myriad

  • Nokia wearables

  • P&G

  • Providence and Swedish

  • Qualcomm employee health

  • RB

  • ResMed

  • TruMed Systems

  • Unilever

AccuVax Logo.JPG
Edwards Health Sciences Logo.jpg
idev logo.jpg
Providence and Swedish Logo.jpg
Qualcomm Logo.jpg
TruMed Systems logo
Clinical Genomics logo
Healthbox logo

Case Studies


Client: Providence Health Services


Pacific N.W. hospital name and identity after merger of regional hospitals.


  • Conducted extensive research: qualitative and quantitative consumer, qualitative and quantitative medical professional, reviewed secondary, investigated religious concerns, best practice examples

  • Extensive creative development and testing

  • Recommended keeping identities separate - risk outweighed upside and cost savings

Client: TruMed Systems


Healthcare startup needed a brand name for vaccine storage and management device.


  • Developed strategic verbal brand identity roadmap

  • Generated more than 550 name candidates, recommending AccuVax

  • During IP screen, discovered that company name was at risk and recommend new name

Client: Edwards Life Sciences


Leading heart device manufacturer needed a themeline for heart valve portfolio to provide competitive separation.


  • Uppercase created “Designed for Life”

  • Speaks to competitive advantage of design expertise

  • Works rationally by suggesting a life-time guarantee

  • Works emotionally by evoking importance of human life

Client: HealthBox


Healthcare incubator sought to establish itself as a thought leader in women’s issues in the life sciences’ space.


  • Uppercase created “Vision51” idea

  • 51% of healthcare workers are female but that is not reflected at the C-level

  • “Vision51” seeks to raise awareness to put more women in the corner office

Client: iRhythm


Innovative cardiac monitoring company requested a short category descriptor that captured their unique selling proposition.


  • After creating and testing more than 75 options, created C.A.M., Continuous Ambulatory Monitoring

  • Rare instance where acronym works; it relates to movement

Client: Qualcomm


This high tech enterprise wanted to generate enthusiasm and participation in its employee wellness program.


  • Uppercase created the brand name WellPort

  • A place for health and wellness as well as tying in with tech aspects

Client: Clinical Genomics


Privately held biotech company needed to brand its ground-breaking diagnostic test for colorectal cancer.


  • Uppercase created the brand name Colvera

  • Semantically, Colvera suggests colon without being heavy handed

  • Linguistically, soft sounds are comforting while ’v’ sound evokes life, e.g. vivid, via, viva, vivo, vitro


Healthcare Press and Thought Leadership




One of our latest screeds:


-       By Mike Pile

Watching the evening news is to be barraged with bad news. Not so much with the news itself, but with the onslaught of pharmaceutical advertisements that can trigger temporary fits of hypochondria in even the healthiest viewer.

Though the maladies themselves sound horrible enough, they barely compare to the tongue twisting names of the drugs designed to treat them. Atazanavir, Trancopal, Zerbaxa, why are drug names so odd? 

Contrary to popular belief, drug brands are not created by over-medicated creative types throwing Scrabble® tiles at each other. In fact, odd drug names are created on purpose because they are practically mandated by the Food and Drug Administration. And this is a good thing. 

The FDA has an alphabet soup of divisions, departments, and offices united by the single mission of reducing injuries caused by confusingly similar drug names. And they pursue this goal by ensuring that each drug name is truly unique. According to the Division of Medication Error Prevention and Analysis, 12.5% of all drug related injuries are due to confusion between drug names. A notable example appeared in 2009 between Durezol, an FDA approved eye medication, and Durasal, an unapproved wart medication. Ouch! 

In addition to avoiding IP issues like patent infringement, trademark infringement, and the clutter of 30,000 US proprietary drug brands and 150,000 drug names in Europe, let alone worldwide, drug marketers jump through a multitude of hoops to conform to FDA guidelines for drug naming. (http://www.fda.gov/downloads/drugs/guidances/ucm398997.pdf)

To eliminate, or at least minimize the potential for confusion, the FDA submits proposed drug names to an exhaustive battery of tests design to weed out names that are similar to others in spelling, pronunciation, and scripted appearance. From the general; does this name sound like another, to the granular; how does this name look when handwritten by a random sample of healthcare providers using different colored ink on lined and unlined paper of different stock, the FDA considers every iteration of every scenario along the prescribing chain to uncover areas of potential confusion.

Individually, the FDA’s tests are too numerous to detail without a casual reader nodding off, but an overview of the process can provide insight, understanding and appreciation for the intense work that goes into the development and testing of a drug brand name.

The Office of Prescription Drug Promotion (OPDP) will reject names that are promotional in nature. In other words, if a proposed name communicates, suggests, or otherwise encourages certain restricted messages or uses, it will not make the cut. Primarily, but not limited to these, names must avoid suggesting that the drug overstates its efficacy, minimizes risk, encourages broader use, or indicates superiority. To illustrate, an asthma drug could not be named BreathBetter, a drug for restless leg syndrome named Run-Fast would be rejected out of hand, and clearly Evercure would not work for any drug. Of course, this poses quite the conundrum for marketers whose very DNA compels them to communicate the features, attributes and benefits of the products they are promoting.

The Division of Medication Error and Prevention Analysis’s scope in brand name review is more expansive and, arguably, more crucial. DMEPA will reject any drug name that suggests or otherwise indicates anything to do with dosing; including form, routes of administration, quantity, units, frequency, strength, etc. For example, they’d rejected Skinject, as it could be construed to suggest a route of administration. They will also reject names that are too close in spelling to another name, too close in pronunciation to another name, or simply too close in appearance to another name. If a few dermatologists write their ‘a’s in a way that looks like the way some neurologists writes their ‘g’s, there could be a problem.

Drug makers must avoid names with spelling similarity, orthographic similarity, phonological similarity, IP infringement, foreign language faux-pas, and promotional messages, so is it any wonder that we take Xeljanz for moderate to severe RA?  Ask your doctor if it is right for you.

For more information, please contact President and Creative Director Mike Pile at Mikep@uppercasebranding.com.